Searchable abstracts of presentations at key conferences in endocrinology

ea0035p611 | Endocrine tumours and neoplasia | ECE2014

TSH suppressive therapy accelerates progression of sacropenia in post-menopausal women

Diedhiou Demba , Klein Marc , Weryha Georges , Feigerlova Eva

Background: TSH-suppressive therapy in patients with differentiated thyroid carcinoma (DTC) leads to iatrogenic thyrotoxicosis and may be associated with alterations in body composition and bone mineral density (BMD). Its effects on a sarcopenia in elderly have not been in detail investigated.Objective: The objective was to compare changes in total and areal lean body mass (LBM), body fat mass (BFM) and BMD in postmenopausal female patients with DTC duri...

ea0073aep580 | Reproductive and Developmental Endocrinology | ECE2021

Adverse effects of gender affirming hormonal therapy in transgender persons: assessing reports in the French pharmacovigilance database

Yelehe Melissa , Klein Marc , Gillet Pierre , Maurier Anais , Feigerlova Eva

BackgroundOnly limited data are available regarding adverse effects of gender affirming hormonal treatment (HT) mainly due to the lack of population-based studies with adequate controls, thus making spontaneous reporting systems a valuable tool to detect potential side reactions.ObjectiveIn this nationwide retrospective study, we aimed to analyse adverse drug reactions (ADRs) in relation to gender affirming H...

ea0063p1150 | Reproductive Endocrinology 2 | ECE2019

Evolution of referrals for gender dysphoria and trends in the sex ratio: Data from the Trans’Est Gender Identity Centre of the University Hospital of Nancy (2002–2018)

Feigerlova Eva , Pascal Veronique , Ganne-Devonec Marie-Odile , Consolandi Pierre , Klein Marc , Guerci Bruno

Background: During the last decennium, an increase in the number of persons referred to gender identity centres has been observed. Epidemiological data have not yet been formally studied in France. Here we report the experience from the TransÂ’Est Gender Identity Centre of the University Hospital of Nancy.Aim: To study the number of people seeking transgender care, the age at referral and the trends in the sex ratio.Methods: Th...

ea0037gp.11.07 | Calcium, Vitamin D and Bone (1) | ECE2015

Tainted vitamin D responses under methyl donor deficiency of the pre-osteoblast cells are caused by a decreased VDR expression and a disruption of PGC-1a: VDR co-regulators complex

Feigerlova Eva , Ewu Essi , Battaglia Shyuefang , Leininger Brigitte , Weryha Georges , Gueant Jean-Louis

Folate and cobalamin are methyl donors (MD) needed for synthesis of methionine, precursor of S-adenosylmethionine (SAM), the substrate of methylation in epigenetic, and epigenomic pathways. The MD deficiency (MDD) leads to a decrease in SAM/SAH ratio and hyperhomocysteinemia, which has been related to osteoporosis in humans and disruption of development of epiphyseal cartilage in rat. However, the underlying molecular mechanisms remain elusive.M...

ea0070aep814 | Reproductive and Developmental Endocrinology | ECE2020

Early impact of cross-sex steroids on body composition and metabolic profile in young transgender subjects

Consolandi Pierre , Pascal Veronique , Samhani Caroline , Larose Clement , Bohme Philip , Marc Klein , Ziegler Olivier , Feigerlova Eva

Background: In females transitioning to males (FtM) and in males transitioning to females (MtF), exogenous cross-sex steroids are prescribed to favour development of secondary characteristics of desired sex, while endogenous hormone production is inhibited.Aims and design: To study early impact of cross-sex steroids on body composition, metabolic profile and pro-inflammatory parameters in young transgender persons before and after 12 months of gender-aff...